BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Shao X, Uojima H, Setsu T, Okubo T, Atsukawa M, Furuichi Y, Arase Y, Hidaka H, Tanaka Y, Nakazawa T, Kako M, Kagawa T, Iwakiri K, Terai S, Koizumi W. Usefulness of autotaxin for the complications of liver cirrhosis. World J Gastroenterol 2020; 26(1): 97-108 [PMID: 31933517 DOI: 10.3748/wjg.v26.i1.97]
URL: https://www.wjgnet.com/1007-9327/full/v26/i1/97.htm
Number Citing Articles
1
María Flores-López, Nuria García-Marchena, Francisco Javier Pavon, Estrella Lara, Oscar Porras-Perales, Pedro Araos, Nerea Requena-Ocaña, Sandra Torres-Galván, M. Carmen Mañas-Padilla, Gabriel Rubio, Juan Suárez, Luis J. Santín, Fernando Rodríguez de Fonseca, Estela Castilla-Ortega, María I. García-Fernández, Antonia Serrano. Plasma Concentrations of Lysophosphatidic Acid and Autotaxin in Abstinent Patients with Alcohol Use Disorder and Comorbid Liver DiseaseBiomedicines 2021; 9(9): 1207 doi: 10.3390/biomedicines9091207
2
Frane Pastrovic, Rudjer Novak, Ivica Grgurevic, Stela Hrkac, Grgur Salai, Marko Zarak, Lovorka Grgurevic, Sona Frankova. Serum proteomic profiling of patients with compensated advanced chronic liver disease with and without clinically significant portal hypertensionPLOS ONE 2024; 19(4): e0301416 doi: 10.1371/journal.pone.0301416
3
Takanobu Iwadare, Takefumi Kimura, Yuki Yamashita, Taiki Okumura, Shun-ichi Wakabayashi, Hiroyuki Kobayashi, Ayumi Sugiura, Tomoo Yamazaki, Satoshi Shimamoto, Koji Igarashi, Satoru Joshita, Takeji Umemura. Serum Autotaxin Levels Predict Liver-Related Events in Patients With Primary Biliary Cholangitis: A Long-Term Multicenter Observational StudyClinical and Translational Gastroenterology 2024; 15(12): e00779 doi: 10.14309/ctg.0000000000000779
4
Jie Zhang, Jiahui Hu, Yu Li, Xuefeng Zhou, Yini Ke, Yi Chen. Serum Autotaxin Level Positively Associates with Metabolic-Associated Fatty Liver Disease and Hyperuricemia in Postmenopausal WomenDigestive Diseases 2024; : 1 doi: 10.1159/000542061
5
Satoshi Iwai, Takemi Akahane, Hiroaki Takaya, Takahiro Kubo, Fumimasa Tomooka, Akihiko Shibamoto, Junya Suzuki, Yuki Tsuji, Yukihisa Fujinaga, Norihisa Nishimura, Koh Kitagawa, Kosuke Kaji, Hideto Kawaratani, Tadashi Namisaki, Masanori Matsumoto, Hitoshi Yoshiji. Ratio of von Willebrand factor to ADAMTS13 is a useful predictor of esophagogastric varices progression after sustained virologic response in patients with hepatitis C virus‐related liver cirrhosisHepatology Research 2024; 54(12): 1116 doi: 10.1111/hepr.14077
6
Yuko Nagaoki, Kenji Yamaoka, Yasutoshi Fujii, Shinsuke Uchikawa, Hatsue Fujino, Atsushi Ono, Eisuke Murakami, Tomokazu Kawaoka, Daiki Miki, Hiroshi Aikata, C. Nelson Hayes, Masataka Tsuge, Shiro Oka. Useful Predictor for Exacerbation of Esophagogastric Varices after Hepatitis C Virus Eradication by Direct-Acting AntiviralsLivers 2024; 4(3): 352 doi: 10.3390/livers4030025
7
Doaa El Wazzan, Ayman F. El-Shayeb, Soraya Hamouda, Mohamed El Shafei, Akram A. Degheidy, Basma Salem, Mohamed Adel. Validity of serum autotaxin and Doppler ultrasound as noninvasive markers of esophageal varices in patients with liver cirrhosisEgyptian Liver Journal 2025; 15(1) doi: 10.1186/s43066-024-00396-7
8
Susmita Bhattarai, Sudha Sharma, Utsab Subedi, Hosne Ara, Alika Shum, Murov Milena, Md. Shenuarin Bhuiyan, Srivatsan Kidambi, Hong Sun, Sumitra Miriyala, Manikandan Panchatcharam. The ATX–LPA Axis Regulates Vascular Permeability during Cerebral Ischemic-ReperfusionInternational Journal of Molecular Sciences 2022; 23(8): 4138 doi: 10.3390/ijms23084138
9
Kuniyuki Kano, Junken Aoki, Timothy Hla. Lysophospholipid Mediators in Health and DiseaseAnnual Review of Pathology: Mechanisms of Disease 2022; 17(1): 459 doi: 10.1146/annurev-pathol-050420-025929
10
Shereen Abou Bakr Saleh, Khaled Mohamed Abdelwahab, Asmaa Mady Mady, Ghada Abdelrahman Mohamed. The impact of achieving a sustained virological response with direct-acting antivirals on serum autotaxin levels in chronic hepatitis C patientsEgyptian Liver Journal 2020; 10(1) doi: 10.1186/s43066-020-00060-w
11
Francesca M. Trovato, Rabiya Zia, Salvatore Napoli, Kate Wolfer, Xiaohong Huang, Phillip E. Morgan, Hannah Husbyn, Marwa Elgosbi, Manuele Lucangeli, Rosa Miquel, Ian Wilson, Nigel David Heaton, Michael A. Heneghan, Georg Auzinger, Charalambos G. Antoniades, Julia A. Wendon, Vishal C. Patel, Muireann Coen, Evangelos Triantafyllou, Mark J. McPhail. Dysregulation of the Lysophosphatidylcholine/Autotaxin/Lysophosphatidic Acid Axis in Acute‐on‐Chronic Liver Failure Is Associated With Mortality and Systemic Inflammation by Lysophosphatidic Acid–Dependent Monocyte ActivationHepatology 2021; 74(2): 907 doi: 10.1002/hep.31738
12
Haruki Uojima, Kadzuki Nakabayashi, Kazumi Yamasaki, Masaya Sugiyama, Norihiro Ishii, Ken Shirabe, Takuya Kyoutou, Koji Ueda, Yoichi Takahama, Nobuharu Tamaki, Masayuki Kurosaki, Hisashi Hidaka, Chika Kusano, Keisuke Amano, Takumi Kawaguchi, Akinobu Taketomi, Satoru Joshita, Takeji Umemura, Miyako Murakawa, Yasuhiro Asahina, Takanori Suzuki, Kentaro Matsuura, Takashi Nishimura, Hiroko Iijima, Kazumasa Sakamoto, Kiyoaki Ito, Sohji Nishina, Keisuke Hino, Hidenori Toyoda, Hiroshi Yatsuhashi, Masayoshi Kage, Masashi Mizokami. New chemiluminescent enzyme immunoassay for quantitative measurement of Mac-2 binding protein glycosylation isomer in chronic liver diseaseJournal of Gastroenterology 2023; 58(12): 1252 doi: 10.1007/s00535-023-02043-1
13
Takanobu Iwadare, Takefumi Kimura, Taiki Okumura, Shun-ichi Wakabayashi, Taro Nakajima, Shohei Kondo, Hiroyuki Kobayashi, Yuki Yamashita, Ayumi Sugiura, Naoyuki Fujimori, Tomoo Yamazaki, Hideo Kunimoto, Satoshi Shimamoto, Koji Igarashi, Satoru Joshita, Naoki Tanaka, Takeji Umemura. Serum autotaxin is a prognostic indicator of liver-related events in patients with non-alcoholic fatty liver diseaseCommunications Medicine 2024; 4(1) doi: 10.1038/s43856-024-00499-7